Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic polymorphisms and expression of HLA-G and its receptors, KIR2DL4 and LILRB1, in non-small cell lung cancer.

Tissue antigens - 1 Jun 2015

Wiśniewski A, Kowal A, Wyrodek E, Nowak I, Majorczyk E, Wagner M, Pawlak-Adamska E, Jankowska R, Ślesak B, Frydecka I, Kuśnierczyk P

Abstract excerpt

Human leukocyte antigen-G (HLA-G) is a nonclassical HLA class I molecule absent from most normal tissues but detected in many malignant tumors. It is recognized by cells of the immune system using LILRB1, KIR2DL4 and LILRB2 receptors. We attempted to find out whether some polymorphisms of HLA-G, LILRB1 and KIR2DL4 genes are associated with susceptibility to nonsmall cell lung cancer (NSCLC). Four polymorphisms in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, CD
Share to Antigens, Neoplasm

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HLA-G Antigens

Share to INDEL Mutation

Share to Lymphatic Metastasis

Share to Neoplasm Invasiveness

Share to Neoplasm Staging

Share to Receptors, Immunologic

Source

Identifiers

PMID: 25855135
DOI: 10.1111/tan.12561

Genes

LILRB1
LILRB2

Variants

rs1632947
rs1632947

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic polymorphisms and expression of HLA-G and its receptors, KIR2DL4 and LILRB1, in non-small cell lung cancer.PMID 25855135Read ↗

KIR2DL2/S2 and HLA-C C1C1 genotype is associated with better response to treatment and prolonged survival of patients with non-small cell lung cancer in a Polish Caucasian population.Semantic proximity Read ↗

KIR-HLA gene diversities and susceptibility to lung cancer.Semantic proximity Read ↗

Frequency changes in HLA-I alleles: A marker to guide immunotherapy in lung adenocarcinoma patients and its relationship with tumor mutational burden and PD-L1 expression.Semantic proximity Read ↗

Genetic variants in the human leukocyte antigen region and survival of Chinese patients with non-small cell lung carcinoma.Semantic proximity Read ↗

Natural killer cell killer immunoglobulin-like gene receptor polymorphisms in non-Hodgkin lymphoma: possible association with clinical course.Semantic proximity Read ↗

Natural killer cell educating KIR/HLA combinations impact survival in anti-PD-L1 treated cancer patientsSemantic proximity Read ↗

Host immune gene polymorphisms were associated with the prognosis of non-small-cell lung cancer in Chinese.Semantic proximity Read ↗

Genetic variant of IRAK2 in the toll-like receptor signaling pathway and survival of non-small cell lung cancer.Semantic proximity Read ↗

Study of the association of LILRB2 gene polymorphisms with colorectal cancer susceptibility and prognosis in Tunisian population.Semantic proximity Read ↗

Association of KIR Genes Polymorphism and its HLA Ligands in Diffuse Large B-cell Lymphoma.Semantic proximity Read ↗

CTLA4 gene variations and haplotypes in patients with lung cancer.Semantic proximity Read ↗

Analysis of KIR gene frequencies and HLA class I genotypes in breast cancer and control group.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.